The cytoplasmic domain of the integrin alpha9 subunit requires the adaptor protein paxillin to inhibit cell spreading but promotes cell migration in a paxillin-independent manner.

The integrin alpha9 subunit forms a single heterodimer, alpha9beta1. The alpha9 subunit is most closely related to the alpha4 subunit, and like alpha4 integrins, alpha9beta1 plays an important role in leukocyte migration. The alpha4 cytoplasmic domain preferentially enhances cell migration and inhibits cell spreading, effects that depend on interaction with the adaptor protein, paxillin. To determine whether the alpha9 cytoplasmic domain has similar effects, a series of chimeric and deleted alpha9 constructs were expressed in Chinese hamster ovary cells and tested for their effects on migration and spreading on an alpha9beta1-specific ligand. Like alpha4, the alpha9 cytoplasmic domain enhanced cell migration and inhibited cell spreading. Paxillin also specifically bound the alpha9 cytoplasmic domain and to a similar level as alpha4. In paxillin(-/-) cells, alpha9 failed to inhibit cell spreading as expected but surprisingly still enhanced cell migration. Further, mutations that abolished the alpha9-paxillin interaction prevented alpha9 from inhibiting cell spreading but had no effect on alpha9-dependent cell migration. These findings suggest that the mechanisms by which the cytoplasmic domains of integrin alpha subunits enhance migration and inhibit cell spreading are distinct and that the alpha9 and alpha4 cytoplasmic domains, despite sequence and functional similarities, enhance cell migration by different intracellular signaling pathways.

[1]  G. Nolan,et al.  Rapid Production of Retroviruses for Efficient Gene Delivery to Mammalian Cells Using 293T Cell–Based Systems , 1999, Current protocols in immunology.

[2]  C. Turner.  Paxillin and focal adhesion signalling , 2000, Nature Cell Biology.

[3]  D. Sheppard,et al.  RGD-independent Binding of Integrin α9β1 to the ADAM-12 and -15 Disintegrin Domains Mediates Cell-Cell Interaction* , 2000, The Journal of Biological Chemistry.

[4]  J. Takagi,et al.  Tissue Transglutaminase, Coagulation Factor XIII, and the Pro-polypeptide of von Willebrand Factor Are All Ligands for the Integrins α9β1 and α4β1 * , 2000, The Journal of Biological Chemistry.

[5]  M. Ginsberg,et al.  Paxillin Binding to a Conserved Sequence Motif in the α4 Integrin Cytoplasmic Domain* , 2000, The Journal of Biological Chemistry.

[6]  J. Takagi,et al.  Tissue transglutaminase, coagulation factor XIII, and the pro-polypeptide of von Willebrand factor are all ligands for the integrins alpha 9beta 1 and alpha 4beta 1. , 2000, The Journal of biological chemistry.

[7]  D. Sheppard,et al.  RGD-independent binding of integrin alpha9beta1 to the ADAM-12 and -15 disintegrin domains mediates cell-cell interaction. , 2000, The Journal of biological chemistry.

[8]  Sheila M. Thomas,et al.  Binding of paxillin to α4 integrins modifies integrin-dependent biological responses , 1999, Nature.

[9]  J. Parsons,et al.  Cell Migration--Movin' On , 1999, Science.

[10]  D. Sheppard,et al.  The Integrin α9β1 Mediates Adhesion to Activated Endothelial Cells and Transendothelial Neutrophil Migration through Interaction with Vascular Cell Adhesion Molecule-1 , 1999, The Journal of cell biology.

[11]  G. Nolan,et al.  Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells , 1998, Cell.

[12]  D. Sheppard,et al.  Identification of the Ligand Binding Site for the Integrin α9β1 in the Third Fibronectin Type III Repeat of Tenascin-C* , 1998, The Journal of Biological Chemistry.

[13]  J. Chen,et al.  Identification of the ligand binding site for the integrin alpha9 beta1 in the third fibronectin type III repeat of tenascin-C. , 1998, The Journal of biological chemistry.

[14]  A. Issekutz,et al.  The β1 integrin, very late activation antigen‐4 on human neutrophils can contribute to neutrophil migration through connective tissue fibroblast barriers , 1997, Immunology.

[15]  D. Sheppard,et al.  Differential regulation of airway epithelial integrins by growth factors. , 1996, American journal of respiratory cell and molecular biology.

[16]  M. Miyasaka,et al.  Rat blood neutrophils express very late antigen 4 and it mediates migration to arthritic joint and dermal inflammation , 1996, The Journal of experimental medicine.

[17]  D. Lauffenburger,et al.  Cell Migration: A Physically Integrated Molecular Process , 1996, Cell.

[18]  T. Springer,et al.  Specialized functional properties of the integrin alpha 4 cytoplasmic domain. , 1995, Molecular biology of the cell.

[19]  J. Brugge,et al.  Integrins and signal transduction pathways: the road taken. , 1995, Science.

[20]  D. Sheppard,et al.  The integrin alpha 9 beta 1 mediates cell attachment to a non-RGD site in the third fibronectin type III repeat of tenascin. , 1994, The Journal of biological chemistry.

[21]  D. Sheppard,et al.  Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle [published erratum appears in J Cell Biol 1994 Feb;124(3):395] , 1993, The Journal of cell biology.

[22]  G. Edelman,et al.  Multiple integrins mediate cell attachment to cytotactin/tenascin. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  Richard O. Hynes,et al.  Integrins: Versatility, modulation, and signaling in cell adhesion , 1992, Cell.

[24]  T. Kupper,et al.  Distinct cellular functions mediated by different VLA integrin α subunit cytoplasmic domains , 1992, Cell.

[25]  T. Kupper,et al.  Distinct cellular functions mediated by different VLA integrin alpha subunit cytoplasmic domains. , 1992, Cell.

[26]  H. Land,et al.  Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.

[27]  M. Elices,et al.  The primary structure of the alpha 4 subunit of VLA‐4: homology to other integrins and a possible cell‐cell adhesion function. , 1989, The EMBO journal.